Skip to main content
. 2009 May 26;27(21):3430–3436. doi: 10.1200/JCO.2008.18.4085

Table 3.

Association of Topo–IIα Amplification With Disease and Treatment Variables

Variable Topo–IIα Amplified Topo–IIα Deleted Topo–IIα Normal P
HER2 IHC 3+, No. of cases 90 50 1.0 < .0001
FISH, ratio 4.5 1.11 1.05 < .0001
S phase, % nuclei 17.5 14 12 .12
ER, % nuclei 55 61 67 .20

NOTE. The values displayed for HER2 IHC, FISH ratio, and S phase are medians and for ER the percentage positive. Differences in the mean ranks or proportions are compared using the Kruskal–Wallis test.

Abbreviations: Topo–IIα, topoisomerase IIα; IHC, immunohistochemistry; FISH, fluorescence in situ hybridization; ER, estrogen receptor.